Sjögren, SE
Agneta Sjögren, Västra Frölunda SE
Patent application number | Description | Published |
---|---|---|
20090157247 | METHOD AND APPARATUS FOR USING AN AUTOMATED LANE KEEPING SYSTEM TO MAINTAIN LATERAL VEHICLE SPACING - A method and apparatus for piloting a vehicle is herein disclosed. The method entails first using a lane keeping system to detect objects in lanes adjacent to the lane currently occupied by the vehicle and then adjusting the position of the vehicle within the occupied lane-relative to a detected object. | 06-18-2009 |
Agneta Sjögren, Västra Frölunda SE
Patent application number | Description | Published |
---|---|---|
20090157247 | METHOD AND APPARATUS FOR USING AN AUTOMATED LANE KEEPING SYSTEM TO MAINTAIN LATERAL VEHICLE SPACING - A method and apparatus for piloting a vehicle is herein disclosed. The method entails first using a lane keeping system to detect objects in lanes adjacent to the lane currently occupied by the vehicle and then adjusting the position of the vehicle within the occupied lane-relative to a detected object. | 06-18-2009 |
Anders Sjögren, Lund SE
Patent application number | Description | Published |
---|---|---|
20130300703 | PRODUCT WITH CODING PATTERN - A product comprises a sheet, which is transparent to visible radiation, and a coding pattern, which comprises scattering dots arranged on the sheet to code information, the scattering dots being arranged to diffusely scatter radiation incident thereon, the coding pattern further comprising reflecting dots arranged on the sheet in correspondence with the scattering dots, the reflecting dots being arranged to specularly reflect radiation incident thereon. | 11-14-2013 |
20130314313 | DISPLAY WITH CODING PATTERN - A display ( | 11-28-2013 |
Anders Sjögren, Lund SE
Patent application number | Description | Published |
---|---|---|
20130300703 | PRODUCT WITH CODING PATTERN - A product comprises a sheet, which is transparent to visible radiation, and a coding pattern, which comprises scattering dots arranged on the sheet to code information, the scattering dots being arranged to diffusely scatter radiation incident thereon, the coding pattern further comprising reflecting dots arranged on the sheet in correspondence with the scattering dots, the reflecting dots being arranged to specularly reflect radiation incident thereon. | 11-14-2013 |
20130314313 | DISPLAY WITH CODING PATTERN - A display ( | 11-28-2013 |
Anita Sjogren, Gothenburg SE
Patent application number | Description | Published |
---|---|---|
20090093054 | CRYOPRESERVATION OF HUMAN BLASTOCYST-DERIVED STEM CELLS BY USE OF A CLOSED STRAW VITRIFICATION METHOD - An improved method for vitrification of biological cells, especially blastocyst-derived stem cells (BS cells). The method is very mild for the cells that remain viable after they have been thawed. The method comprises, i) transfer of the cells to a first solution (solution A), ii) optionally incubation of the cells in the first solution, iii) transfer the cells obtained in step i) or ii) to a second solution (solution B), iv) optionally incubation of the cells in the second solution, v) transfer of the cells obtained from step iii) or iv) into one or more closed straws with dimensions that allow a volume of at least 20 μl to be contained in them vi) sealing the one or more closed straws, and vii) vitrification of the one or more closed straws. An important feature of the present invention is the use of closed straw and that relatively large volumes can be efficiently vitrified and subsequently thawed. | 04-09-2009 |
Christer Sjogren, Viken SE
Patent application number | Description | Published |
---|---|---|
20110020265 | USE OF OLIGOMERS OF LACTIC ACID IN THE TREATMENT OF GYNAECOLOGICAL DISORDERS - Use of the one or more oligomers of lactic acid with the following formula (I) wherein n is an integer from 2 to 25 such as, e.g., from 2 to 20, from 3 to 25, from 3 to 20, from 2 to 15, from 3 to 15, from 2 to 10, from 3 to 10, from 4 to 10, or from 4 to 9 or a lactic acid oligomeric product for the prophylaxis and/or treatment of a disease or condition that benefit of an acidic environment especially a gynaecological infection such as a bacterial infection, such as bacterial vaginosis, unspecific colpitis, senile colpitis, cervicitis, and urethritis, a fungal infection, such as candidosis ( | 01-27-2011 |
Dan Sjögren, Loddekopinge SE
Patent application number | Description | Published |
---|---|---|
20110209061 | METHOD FOR PLAYING BACK AUDIO FILES WITH AN AUDIO REPRODUCTION DEVICE - A method for playing back audio files with an audio reproduction device and an audio reproduction device are described. | 08-25-2011 |
Hans Olov Sjogren, Lund SE
Patent application number | Description | Published |
---|---|---|
20130309198 | COMPOSITION COMPRISING AT LEAST TO COMPOUNDS WHICH INDUCES INDOLAMINE 2,3 - DIOXYGENASE (IDO), FOR THE TREATMENT OF AN AUTOIMMUNE DISORDER OR SUFFERING FROM IMMUNE REJECTION OF ORGANS - A composition and method for using a composition, the composition having at least two compounds, each of which induces indolamine 2,3-dioxygenase, for the treatment of an autoimmune disorder or disease or immune rejection of transplants or gene therapeutically modified cells, wherein the inducers have different mechanism of action and wherein the composition gives rise to a synergistic effect on the IDO levels. | 11-21-2013 |
20150182592 | Composition Comprising At Least Two Compounds Which Induce Indolamine 2,3 - Dioxygenase (IDO), for the Treatment of an Autoimmune Disorder or Suffering from Immune Rejection of Organs - A composition and method for using a composition, the composition having at least two compounds, each of which induces indolamine | 07-02-2015 |
20160068809 | USE OF ZEBURALINE FOR THE TREATMENT OF AUTOIMMUNE DISEASES OR IMMUNE REJECTION OF TRANSPLANTS - The invention relates to the use of 1-(β-D-Ribofuranosyl)-1,2-dihydropyrimidin-2-one derivative or mimetic or an analogue, derivatives, metabolites, variants or salts thereof for the manufacturing of a medicament to increase the amount of Indoleamine 2,3-dioxygenase (IDO) production in order to induce immunological tolerance as well as a method of treating a mammal in need thereof. | 03-10-2016 |
Hans Olov Sjögren, Lund SE
Patent application number | Description | Published |
---|---|---|
20110300142 | USE OF ZEBURALINE FOR THE TREATMENT OF AUTOIMMUNE DISEASES OR IMMUNE REJECTION OF TRANSPLANTS - The invention relates to the use of 1-(β-D-Ribofuranosyl)-1,2-dihydropyrimidin-2-one derivative or mimetic or an analogue, derivatives, metabolites, variants or salts thereof for the manufacturing of a medicament to increase the amount of Indoleamine 2,3-dioxygenase (IDO) production in order to induce immunological tolerance as well as a method of treating a mammal in need thereof. | 12-08-2011 |
Helen Ulrika Sjögren, Lund SE
Patent application number | Description | Published |
---|---|---|
20130210727 | STABILIZATION OF FSH - The present invention, pertains in general to the field of stabilization of FSH formulations, in particular liquid FSH formulations. The stabilization is achieved by the addition of salts comprising pharmaceutically acceptable alkali metal cations, in preferred embodiments by the addition of pharmaceutically acceptable salts, i.e. sodium salts or potassium salts. | 08-15-2013 |
Helen Ulrika Sjögren, Lund SE
Patent application number | Description | Published |
---|---|---|
20130210727 | STABILIZATION OF FSH - The present invention, pertains in general to the field of stabilization of FSH formulations, in particular liquid FSH formulations. The stabilization is achieved by the addition of salts comprising pharmaceutically acceptable alkali metal cations, in preferred embodiments by the addition of pharmaceutically acceptable salts, i.e. sodium salts or potassium salts. | 08-15-2013 |
20150265681 | STABILIZATION OF FSH - The present invention pertains in general to the field of stabilization of FSH formulations, in particular liquid FSH formulations. The stabilization is achieved by the addition of salts comprising pharmaceutically acceptable alkali metal cations, in preferred embodiments by the addition of pharmaceutically acceptable salts, i.e. sodium salts or potassium salts. | 09-24-2015 |
Jan Sjogren, Farjestaden SE
Patent application number | Description | Published |
---|---|---|
20100196178 | METERING PUMP - The invention relates to a metering pump for feeding out viscous materials, which pump comprises a housing having an inlet, connectable to a viscous material source, and an outlet; a valve body of cylindrical basic shape, which is rotatable into at least two positions by means of a drive unit, a first position allowing a flow of the said material from the inlet to the housing and a second position allowing a flow of the said material from the housing to the outlet. The pump also comprises a cylinder device connected to the housing, having a controllable piston intended to achieve the said flow of material, and at least one device for cleaning the metering pump. The said cleaning device comprises at least one nozzle for cleaning agent, disposed in a valve-body-facing part of the piston. The invention also relates to a method for cleaning such a metering pump. | 08-05-2010 |
Jesper Sjögren, Helsingborg SE
Patent application number | Description | Published |
---|---|---|
20100320207 | RESEALABLE CONTAINER - The present invention relates to a container ( | 12-23-2010 |
Jesper Sjögren, Helsingborg SE
Patent application number | Description | Published |
---|---|---|
20100320207 | RESEALABLE CONTAINER - The present invention relates to a container ( | 12-23-2010 |
Jesper Sjögren, Nyhamnslage SE
Patent application number | Description | Published |
---|---|---|
20140150925 | Connector for Fluid Communication - A fluid connector for selectively establishing fluid communication between a first medical container and a second medical container is provided. The fluid connector includes an adapter configured to removably attach to the first container. The adapter includes an access port and a cap. The connector further includes an outer sleeve connected to the adapter and a tubular body retained at least partially within the outer sleeve. The body has a proximal end connected to the adapter and a distal end connected to the second container. The fluid connector is transitionable from a first position in which the first container and the second container are in fluid isolation to a second position in which the first container and the second container are in fluid communication. At least a portion of the cap of the adapter is retained within the outer sleeve. | 06-05-2014 |
Joakim Sjogren, Koping SE
Patent application number | Description | Published |
---|---|---|
20080213075 | System and a Method of Controlling the Tilting of a Loadcarrying Implement of a Movable Work Machine, and a Movable Work Machine - A system is provided for controlling the tilting of a load-carrying implement of a movable work machine that includes a frame and the implement, pivotally connected to the frame, and a tilting arrangement for tilting the implement in relation to the frame. The system includes a control for controlling the tilting of the implement based upon a sensor-registered movement of the movable work machine, and for controlling the tilting of the implement such that the implement counteracts the inertia of a load carried by the implement. | 09-04-2008 |
20080245591 | Anti Spinning Device, a Vehicle Comprising the Device and a Method for Reducing Slip During Advancing of a Vehicle - An anti spinning device for a powered vehicle is provided. The vehicle includes at least one driveline, the driveline including a power source and at least one rotatable element, which power source is connected to and arranged to transmit power to the at least one rotatable element. The anti spinning device includes an arrangement for detecting the fulfilment of a preset condition and an arrangement for interrupting the power transmission to the individual rotatable element when the preset condition is fulfilled. A method for controlling an anti spinning device, and a vehicle and a work vehicle such an anti spinning device, are also provided. | 10-09-2008 |
20080319618 | Method for Optimizing Operation of a Work Vehicle - A method is provided for optimizing operation of a work vehicle with an engine for propelling the vehicle. The method includes detecting at least one operating parameter, determining an optimized engine speed parameter value with regard to fuel consumption, reduced emissions and/or increased productivity on the basis of the detected operating parameter and stored information regarding fuel consumption, emissions and/or productivity, and controlling the engine in accordance with the determined engine speed parameter value. | 12-25-2008 |
Jonathan Sjogren, Lund SE
Patent application number | Description | Published |
---|---|---|
20140065128 | TREATMENT FOR IgE-MEDIATED DISEASE - The invention provides an EndoS polypeptide, or a polynucleotide encoding an EndoS polypeptide, for use in a method for treating or preventing a disease or condition mediated by IgE antibodies. | 03-06-2014 |
20140302519 | ENDOGLYCOSIDASE FROM STREPTOCOCCUS PYOGENES AND METHODS USING IT - The invention provides an endoglycosidase, referred to as EndoS49 and having the amino acid sequence of SEQ ID NO: 1. EndoS49 was isolated from | 10-09-2014 |
Klara Sjögren, Åsa SE
Patent application number | Description | Published |
---|---|---|
20160067289 | PROBIOTIC STRAINS FOR USE IN TREATMENT OR PREVENTION OF OSTEOPOROSIS - The present invention relates to at least one probiotic strain chosen from | 03-10-2016 |
Magnus Sjögren, Tjornarp SE
Patent application number | Description | Published |
---|---|---|
20120228085 | SYSTEM FOR ROTATING A NUMBER OF PACKAGES - A conveyor belt system is provided for enabling rotation of a number of packages, such that every second package is rotated clockwise, and every other package is rotated counter clockwise. A computer program product is also provided. | 09-13-2012 |
Martin Sjogren, Vastra Frolunda SE
Patent application number | Description | Published |
---|---|---|
20090124634 | Novel dipodazine compounds and applications - The invention relates to a novel class of dipodazine derivatives, suitable for use as surface on-growth inhibiting agents. | 05-14-2009 |
20150075543 | SMOKELESS TOBACCO COMPOSITION COMPRISING NON-TOBACCO FIBERS AND A METHOD FOR ITS MANUFACTURE - A smokeless tobacco composition comprising at least one type of non-tobacco fibers, wherein the non-tobacco fibers have an average length-to-width ratio equal to or greater than 3.5:1 and equal to or lower than 100:1, and a method for manufacturing the smokeless tobacco composition. | 03-19-2015 |
Martin Sjogren, Stromstad SE
Patent application number | Description | Published |
---|---|---|
20090099068 | ON-GROWTH INHIBITING COMPOUNDS - An on-growth inhibiting agent, for the inhibition and/or prevention of on-growth of biological organisms on objects or living beings, includes at least one cyclotide, and a suitable carrier medium. A plant extract containing a mixture of cyclotides is also usable. | 04-16-2009 |
Mikael Sjogren, Alunda SE
Patent application number | Description | Published |
---|---|---|
20120090716 | SIMULATOR DEVICE - A simulator device configured to replace a filtration unit in a crossflow filtration system comprises a feed inlet ( | 04-19-2012 |
Mikael Sjögren, Fjardhundra SE
Patent application number | Description | Published |
---|---|---|
20100016935 | MEDICAL IMPLANTABLE LEAD - A implantable lead an elongate body including a flexible insulating tube, and a tubular conductor layer formed of multiple separate strip conductors, which are arranged at the outer surface of the insulating tube and extend along the length thereof. | 01-21-2010 |
20100114279 | MEDICAL IMPLANTABLE LEAD - A medical implantable lead has a proximal end and a distal end, and a flexible flat elongate body. The elongate body includes a layer of strip conductors extending along the length of the flat elongate body, a top insulating layer, and a bottom insulating layer. The layer of strip conductors is sealingly enclosed between the top and bottom insulating layers, and at least a major portion of the flat elongate body is twisted into an elongate helical portion having a central cavity extending longitudinally of the helical portion. | 05-06-2010 |
20100168806 | DEVICE AND METHOD FOR TREATING CARDIAC TISSUE OF A HEART OF A PATIENT WITH THERAPEUTIC LIGHT USING PHOTOBIOMODULATION - For treatment of cardiac tissue of a heart of a patient with therapeutic light using an implantable medical device connectable to at least one medical lead carrying electrodes and at least one fixation element that fixes the lead at a fixation area of the cardiac tissue, therapeutic light is emitted toward the at least one fixation area of cardiac tissue and/or toward a contact area between the at least one electrode and cardiac tissue using an intracorporeal light emitter. | 07-01-2010 |
20100280563 | DEVICE AND METHOD FOR DETECTING AND TREATING A MYOCARDIAL INFARCTION USING PHOTOBIOMODULATION - In an implantable medical device and a method for treating cardiac tissue of a heart of a patient with therapeutic light, a myocardial infarction is detected and a location the myocardial infarction is identified. A therapy session is initiated by selectively activating one or more of a number of light emitting units arranged in at least one medical lead connectable to the implantable medical device, to emit therapeutic light toward the detected location of the myocardial infarction upon detection of an occurrence of the myocardial infarction. | 11-04-2010 |
20110040291 | TISSUE STIMULATING DEVICE AND METHOD - A tissue stimulating device that provides a biological stimulation of tissue has a release surface adapted for arrangement adjacent to a tissue to be stimulated. An agent reservoir of the device includes an ionic agent capable of causing a stimulation if present at sufficient high extracellular concentration close to the tissue. An agent releaser is provided in the device for releasing a selected amount of the ionic agent from the agent reservoir to an outside of the release surface at a stimulation occasion for stimulating the tissue. The ionic agent will cause a temporary change in ion permeability of the tissue cell membranes and a depolarization of the tissue cells. | 02-17-2011 |
Mikael Sjögren, Fjardhundra SE
Patent application number | Description | Published |
---|---|---|
20080288014 | Strain Reliever for a Lead of an Implantable Heart Stimulator - A strain reliever for a lead of an implantable heart stimulator, the lead including at least one cable having an electric conductor, has a body of electrically conducting material in electric contact with the electric conductor. The body is lockable in a position in electric contact with electric circuitry of the heart stimulator. The body has a fastening arrangement for fastening the proximal end of the cable at the fastening point on the peripheral surface of the body located at a distance from the distal end of the body. A fixing arrangement is provided at the distal end of the body for fixing the cable to extend in the distal direction from a departure point at the body distal end. The cable is intended to extend in a helical path on the peripheral surface of the body between the fastening point and the departure point. | 11-20-2008 |
20100016935 | MEDICAL IMPLANTABLE LEAD - A implantable lead an elongate body including a flexible insulating tube, and a tubular conductor layer formed of multiple separate strip conductors, which are arranged at the outer surface of the insulating tube and extend along the length thereof. | 01-21-2010 |
20100114279 | MEDICAL IMPLANTABLE LEAD - A medical implantable lead has a proximal end and a distal end, and a flexible flat elongate body. The elongate body includes a layer of strip conductors extending along the length of the flat elongate body, a top insulating layer, and a bottom insulating layer. The layer of strip conductors is sealingly enclosed between the top and bottom insulating layers, and at least a major portion of the flat elongate body is twisted into an elongate helical portion having a central cavity extending longitudinally of the helical portion. | 05-06-2010 |
20100168806 | DEVICE AND METHOD FOR TREATING CARDIAC TISSUE OF A HEART OF A PATIENT WITH THERAPEUTIC LIGHT USING PHOTOBIOMODULATION - For treatment of cardiac tissue of a heart of a patient with therapeutic light using an implantable medical device connectable to at least one medical lead carrying electrodes and at least one fixation element that fixes the lead at a fixation area of the cardiac tissue, therapeutic light is emitted toward the at least one fixation area of cardiac tissue and/or toward a contact area between the at least one electrode and cardiac tissue using an intracorporeal light emitter. | 07-01-2010 |
20100280563 | DEVICE AND METHOD FOR DETECTING AND TREATING A MYOCARDIAL INFARCTION USING PHOTOBIOMODULATION - In an implantable medical device and a method for treating cardiac tissue of a heart of a patient with therapeutic light, a myocardial infarction is detected and a location the myocardial infarction is identified. A therapy session is initiated by selectively activating one or more of a number of light emitting units arranged in at least one medical lead connectable to the implantable medical device, to emit therapeutic light toward the detected location of the myocardial infarction upon detection of an occurrence of the myocardial infarction. | 11-04-2010 |
20110040291 | TISSUE STIMULATING DEVICE AND METHOD - A tissue stimulating device that provides a biological stimulation of tissue has a release surface adapted for arrangement adjacent to a tissue to be stimulated. An agent reservoir of the device includes an ionic agent capable of causing a stimulation if present at sufficient high extracellular concentration close to the tissue. An agent releaser is provided in the device for releasing a selected amount of the ionic agent from the agent reservoir to an outside of the release surface at a stimulation occasion for stimulating the tissue. The ionic agent will cause a temporary change in ion permeability of the tissue cell membranes and a depolarization of the tissue cells. | 02-17-2011 |
Olof Sjogren, Mölndal SE
Patent application number | Description | Published |
---|---|---|
20110021534 | 2 -SUBSTITUTED- 3 -PHENYLPROPIONIC ACID DERIVATIVES AND THEIR USE IN THE TREATMENT OF INFLAMMATORY BOWEL DISEASE - The present invention relates to 2-(substituted sulphur, sulphone or sulphoxide)-3-(substituted phenyl) propionic acid derivatives, 2-(substituted oxygen)-3-(substituted phenyl) propionic acid derivatives, benzoic acid derivatives, and derivatives of 2-methyl-2-(phenoxy or phenylthio)propanoic acid and 2-(methylor ethyl)-2-(phenoxy or phenylthio)butanoic acid, to processes for preparing such compounds, to their use in the treatment of inflammatory conditions, and to pharmaceutical compositions containing them. | 01-27-2011 |
Olof Sjogren, Mölndal SE
Patent application number | Description | Published |
---|---|---|
20110021534 | 2 -SUBSTITUTED- 3 -PHENYLPROPIONIC ACID DERIVATIVES AND THEIR USE IN THE TREATMENT OF INFLAMMATORY BOWEL DISEASE - The present invention relates to 2-(substituted sulphur, sulphone or sulphoxide)-3-(substituted phenyl) propionic acid derivatives, 2-(substituted oxygen)-3-(substituted phenyl) propionic acid derivatives, benzoic acid derivatives, and derivatives of 2-methyl-2-(phenoxy or phenylthio)propanoic acid and 2-(methylor ethyl)-2-(phenoxy or phenylthio)butanoic acid, to processes for preparing such compounds, to their use in the treatment of inflammatory conditions, and to pharmaceutical compositions containing them. | 01-27-2011 |
Per Olof Sjögren, Molndal SE
Patent application number | Description | Published |
---|---|---|
20110166157 | 2-Substituted-3-Phenylpropionic Acid Derivatives and Their Use in the Treatment of Inflammatory Bowel Disease - The present invention relates to 2-(substituted sulphur, sulphone or sulphoxide)-3-(substituted phenyl)propionic acid derivatives, 2-(substituted oxygen)-3-(substituted phenyl)propionic acid derivatives, benzoic acid derivatives, and derivatives of 2-methyl-2-(phenoxy or phenylthio)propanoic acid and 2-(methyl or ethyl)-2-(phenoxy or phenylthio)butanoic acid, to processes for preparing such compounds, to their use in the treatment of inflammatory conditions, and to pharmaceutical compositions containing them. | 07-07-2011 |
Sven Sjögren, Molndal SE
Patent application number | Description | Published |
---|---|---|
20090118192 | METHODS USEFUL IN THE TREATMENT OF BONE RESORPTION DISEASES - The invention relates to a combined pharmaceutical preparation comprising parathyroid hormone and a bone resorption inhibitor, said preparation being adapted for (a) the administration of parathyroid hormone during a period of approximately 6 to 24 months; (b) after the administration of parathyroid hormone has been terminated, the administration of a bone resorption inhibitor during a period of approximately 12 to 36 months. | 05-07-2009 |
20110071081 | METHODS USEFUL IN THE TREATMENT OF BONE RESORPTION DISEASES - The invention relates to a combined pharmaceutical preparation comprising parathyroid hormone and a bone resorption inhibitor, said preparation being adapted for (a) the administration of parathyroid hormone during a period of approximately 6 to 24 months; (b) after the administration of parathyroid hormone has been terminated, the administration of a bone resorption inhibitor during a period of approximately 12 to 36 months. | 03-24-2011 |
Sven Sjögren, Molndal SE
Patent application number | Description | Published |
---|---|---|
20110071081 | METHODS USEFUL IN THE TREATMENT OF BONE RESORPTION DISEASES - The invention relates to a combined pharmaceutical preparation comprising parathyroid hormone and a bone resorption inhibitor, said preparation being adapted for (a) the administration of parathyroid hormone during a period of approximately 6 to 24 months; (b) after the administration of parathyroid hormone has been terminated, the administration of a bone resorption inhibitor during a period of approximately 12 to 36 months. | 03-24-2011 |
20120148684 | METHODS USEFUL IN THE TREATMENT OF BONE RESORPTION DISEASES - The invention relates to a combined pharmaceutical preparation comprising parathyroid hormone and a bone resorption inhibitor, said preparation being adapted for (a) the administration of parathyroid hormone during a period of approximately 6 to 24 months; (b) after the administration of parathyroid hormone has been terminated, the administration of a bone resorption inhibitor during a period of approximately 12 to 36 months. | 06-14-2012 |
Tommy Sjögren, Malmo SE
Patent application number | Description | Published |
---|---|---|
20100136969 | Neighbor Cell List Compilation Methods and Apparatus - A user equipment (UE) in a communication system can keep track of the cell/frequency deployment of a network operator preferred by the user, and based on the tracked information, the UE can build up its own user-specific Neighbor Cell List. When the UE is roaming, the UE does received-signal measurements according to cells and carrier frequencies identified in the broadcast Neighbor Cell Lists of the roamed-into network, but the UE also does received-signal measurements (with higher priority) according to the user-specific Neighbor Cell List that it has built up. Accordingly, a UE implementing a user-specific Neighbor Cell List analyzes its radio environment based on received signals and stores information about that environment, including user-preference information that prioritizes cells in the radio environment. The UE can then carry out cell search based on the stored environment and user-preference information. | 06-03-2010 |
20100150062 | Packet Indicator for RLC Protocol - In a communication terminal implementing a radio link control (RLC) protocol, error propagation to higher layer protocols is mitigated by use of an additional length indicator, referred to herein as a new packet indicator, in the RLC data blocks to indicate the beginning of a new higher layer packet in addition to a conventional length indicator to indicate the last segment of a higher layer packet. The new packet indicator prevents the LLC data segment at the beginning of an RLC data block from being concatenated with an LLC data segment in the previous data block even when length indicators in the previous data block are not received. | 06-17-2010 |
Tommy Sjögren, Genarp SE
Patent application number | Description | Published |
---|---|---|
20100091674 | Radio Carrier Identification Methods and Apparatus - A user equipment (UE) in a communication system measures the power received in a bandwidth on possible downlink carriers in a frequency band that is supported by the UE in order to search for available carriers. Search times can be decreased on average by using a specially configured filter to process the received power measurements and then determining likely carriers based on the filtered values. Metrics from the filter can be used to indicate both where to perform cell search and where not to perform cell search. | 04-15-2010 |
Tommy Sjögren, Malmo SE
Patent application number | Description | Published |
---|---|---|
20100150062 | Packet Indicator for RLC Protocol - In a communication terminal implementing a radio link control (RLC) protocol, error propagation to higher layer protocols is mitigated by use of an additional length indicator, referred to herein as a new packet indicator, in the RLC data blocks to indicate the beginning of a new higher layer packet in addition to a conventional length indicator to indicate the last segment of a higher layer packet. The new packet indicator prevents the LLC data segment at the beginning of an RLC data block from being concatenated with an LLC data segment in the previous data block even when length indicators in the previous data block are not received. | 06-17-2010 |
Tommy Sjögren, Malmõ SE
Patent application number | Description | Published |
---|---|---|
20100136969 | Neighbor Cell List Compilation Methods and Apparatus - A user equipment (UE) in a communication system can keep track of the cell/frequency deployment of a network operator preferred by the user, and based on the tracked information, the UE can build up its own user-specific Neighbor Cell List. When the UE is roaming, the UE does received-signal measurements according to cells and carrier frequencies identified in the broadcast Neighbor Cell Lists of the roamed-into network, but the UE also does received-signal measurements (with higher priority) according to the user-specific Neighbor Cell List that it has built up. Accordingly, a UE implementing a user-specific Neighbor Cell List analyzes its radio environment based on received signals and stores information about that environment, including user-preference information that prioritizes cells in the radio environment. The UE can then carry out cell search based on the stored environment and user-preference information. | 06-03-2010 |